Pro Medicus Limited
ASX-PME
Company Overview
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Name
Pro Medicus Limited
CEO
Dr. Sam Aaron Hupert M.B.B.S., M.D.
Website
www.promed.com.au
Sector
Health Care Technology
Year Founded
1983
Profile
Market Cap
A$17.91B
EV
A$17.75B
Shares Out
104.5M
Revenue
A$161.5M
Employees
—
Margins
Gross
99.81%
EBITDA
70%
Operating
69.84%
Pre-Tax
72.13%
Net
51.27%
FCF
50.57%
Returns (5Yr Avg)
ROA
29.65%
ROTA
60.01%
ROE
45.07%
ROCE
46.92%
ROIC
65.27%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
A$128.25
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
A$155.43M
Net Debt
-A$153.36M
Debt/Equity
0.01
EBIT/Interest
—
Growth (CAGR)
Rev 3Yr
33.38%
Rev 5Yr
26.37%
Rev 10Yr
27.46%
Dil EPS 3Yr
38.93%
Dil EPS 5Yr
34.01%
Dil EPS 10Yr
48.67%
Rev Fwd 2Yr
25.99%
EBITDA Fwd 2Yr
28.43%
EPS Fwd 2Yr
31.13%
EPS LT Growth Est
35.88%
Dividends
Yield
—
Payout
50.46%
DPS
A$0.4
DPS Growth 3Yr
38.67%
DPS Growth 5Yr
37.97%
DPS Growth 10Yr
34.93%
DPS Growth Fwd 2Yr
32.86%